We have received funding from:

  • National Health & Medical Research Council - Engineering human dendritic cells for tolerogenic gene therapy of type 1 diabetes. 
  • National Health and Medical Research Council - Deciphering how TCR affinity regulates CD4 T cell help in immunity and autoimmunity.
  • Ovarian Cancer Research Council Re-activating anti-tumour immunity by targeting N-MYC-Let7 axis in ovarian cancer.
  • Tour de Cure - A new checkpoint molecule.


We collaborate with Mater Research Institute-UQ on the study of immune responses in humanized mice. We collaborate with The Centenary Institute on studies of immune tolerance and QIMRB on anti-tumour immunity. We have established collaborations widely across UQ.